FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Ascend Laboratories Olmesartan Medoxomil Tablets 20 mg Recall

Olmesartan Medoxomil Tablets 20 mg, Rx Only, 90 Tablets per Bottle, Manufactured by: Al…

Ascend Laboratories LLC · Parsippany, NJ

Risk level
Class II
Reported by FDA
Feb 12, 2020
Recall ID
D-0828-2020
Check your lot numberHow we source this data

Summary

Ascend Laboratories recalled Olmesartan Medoxomil Tablets 20 mg starting Jan 24, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0828-2020 on Feb 12, 2020. Reason: cGMP Deviations; Olmesartan Medoximil Tablets 20 mg was released in error with alternate API source prior to filing and approval of Prior Approval Supplement. Status: Terminated.

Why it was recalled

cGMP Deviations; Olmesartan Medoximil Tablets 20 mg was released in error with alternate API source prior to filing and approval of Prior Approval Supplement.

Product description

Olmesartan Medoxomil Tablets 20 mg, Rx Only, 90 Tablets per Bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC 67877-446-90.

Lot numbers, UPCs & expiration codes

Lot #: 19122552, Exp 7/31/2021

Where it was sold

Nationwide in the U.S.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0828-2020
Classification
Class II
Status
Terminated
Recall initiated
Jan 24, 2020
FDA report date
Feb 12, 2020
Quantity
192 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Ascend Laboratories LLC

Original FDA data

Every field from FDA enforcement report D-0828-2020, exactly as published.

Show all FDA fields
City
Parsippany
State
NJ
Status
Terminated
Country
United States
Event ID
84818
Address
339 Jefferson Rd Ste 101
Code information
Lot #: 19122552, Exp 7/31/2021
Postal code
07054-3707
Report date
Feb 12, 2020
Product type
Drugs
Recall number
D-0828-2020
Classification
Class II
Recalling firm
Ascend Laboratories LLC
Product quantity
192 Bottles
Termination date
Oct 29, 2021
Reason for recall
cGMP Deviations; Olmesartan Medoximil Tablets 20 mg was released in error with alternate API source prior to filing and approval of Prior Approval Supplement.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Olmesartan Medoxomil Tablets 20 mg, Rx Only, 90 Tablets per Bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC 67877-446-90.
Distribution pattern
Nationwide in the U.S.
Recall initiation date
Jan 24, 2020
Initial firm notification
Letter
Center classification date
Feb 6, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0828-2020, published Feb 12, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls